Nature Cancer

🚨Our JUNE Issue is OUT NOW! ☀️ Check it out here: 🔗nature.com/natcancer/volu…

🌟New article online @NatureCancer by L. Galluzzi's team 👇 doi.org/10.1038/s43018…

Check out a new Review article on clonal hematopoiesis by Jen Trowbridge and collaborators @NatureCancer doi.org/10.1038/s43018…

🌟Another timely Review @NatureCancer, by G. Dotti and collaborators 👇 doi.org/10.1038/s43018…

Our Senior Editor Elena Skourti @skourti_elena is attending the @AACR Special Conference in Artificial Intelligence & Machine Learning this week. If you are there, find her and connect!

🚨 Clinical Trial published @NatureCancer ! David Cibula and colleagues report on the final outcome of the SENTIX international trial, assessing sentinel LN biopsy without systematic pelvic lymphadenectomy in early-stage cervical cancer. 🔗nature.com/articles/s4301…

🚨New Article Alert from @NatureCancer ! 'Self-amplifying NRF2–EZH2 epigenetic loop converts KRAS-initiated progenitors to invasive pancreatic cancer' ✏️ By Michael Karin and colleagues 🔗 nature.com/articles/s4301…

📢Another Article ONLINE @NatureCancer 'Profiling antigen-binding affinity of B cell repertoires in tumors by deep learning predicts immune-checkpoint inhibitor treatment outcomes' ✒️By Junzhou Huang, David Gerber, Tao Wang and colleagues 🔗nature.com/articles/s4301…

🚨New Article ONLINE @natureCancer ! 'Multipotent lineage potential in B cell acute lymphoblastic leukemia is associated with distinct cellular origins and clinical features' ✒️ By John Dick, Charles Mullighan and colleagues 🔗nature.com/articles/s4301…

📢Another REVIEW now ONLINE @Naturecancer 'Advancing therapeutics in small-cell lung cancer' ✒️By Anish Thomas, Chirayu Mohindroo & Giuseppe Giaccone 🔗nature.com/articles/s4301…

🚨Read this REVIEW published @NatureCancer ! 'The tumor microenvironment’s role in the response to immune checkpoint blockade' ✏️By Vassiliki Boussiotis and co-authors 🔗nature.com/articles/s4301…

🚨 New article alert! 🚨 Check out our last release Christophe Le Tourneau and colleague on "Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial" 👉 nature.com/articles/s4301…

New Article out @NatureCancer 'p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy' ✒️By Linda McAllister-Lucas, Peter Lucas, Dong Hu and colleagues 🔗nature.com/articles/s4301…

⭐️New Article ONLINE @NatureCancer ! Concurrent inhibition of tumor growth and metastasis by a lipidated nanophotosensitizer tracing and disabling tumor extracellular vesicles ✏️By Xiaorui Wang and colleagues 🔗nature.com/articles/s4301…

📢We’ve partnered with MD Anderson to explore recent breakthroughs in understanding the tumor ecosystem and how its various components influence cancer development, progression, diagnosis, and treatment. Learn more and save your seat! 🔗go.nature.com/44cJT9Z

🚨Our JUNE Issue is OUT NOW! ☀️ Check it out here: 🔗nature.com/natcancer/volu…

📢New Article published @NatureCancer ! 'Innate immunity and the NF-κB pathway control prostate stem cell plasticity, reprogramming and tumor initiation' ✒️By Cédric Blanpain and colleagues 🔗nature.com/articles/s4301…

🚨 New article alert! 🚨 Check out our last release by Eric M. Thompson and colleagues, testing a peptide vaccine in CAYA with recurrent high-grade glioma and medulloblastoma in their phase I trial 🧠 👉 nature.com/articles/s4301…

Our Senior Editor Elena Skourti @skourti_elena is attending the @pezcoller Symposium this week. If you are there, find her and connect!

🚨Join us for this webinar TODAY!